Publications by authors named "Tracy Wiczer"

Claim this Profile
A
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.
John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra, Mussammat Ferdousi, Onaopepo Kola-Kehinde, Tracy Wiczer

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?
Gretchen A McNally, Connor M Aossey, Tracy Wiczer, Loraine T Sinnott, Mark Lustberg

Leuk Lymphoma· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: State-of-the-Art Review.
Cooper Quartermaine, Sanam M Ghazi, Aneeq Yasin, Farrukh T Awan, Michael Fradley, Tracy Wiczer

JACC CardioOncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.
Timothy Schieber, Anthony Li, Jordan Lundberg, Tracy Wiczer, Timothy Voorhees

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of bleeding events in patients receiving acalabrutinib therapy.
Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy.
Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
Benjamin Buck, Aaron P Chum, Mitkumar Patel, Rebecca Carter, Haseeb Nawaz, Tracy Wiczer

JAMA Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventricular arrhythmias and sudden death events following acalabrutinib initiation.
Seema A Bhat, John Gambril, Leylah Azali, Sunnia T Chen, Lindsay Rosen, Tracy E Wiczer

Blood· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation.
Sunnia T Chen, Leylah Azali, Lindsay Rosen, Qiuhong Zhao, Tracy Wiczer

J Hematol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia.
Soun Khountham, Polina Shindiapina, Xiaokui Mo, Curtis Lachowiez, Tracy Wiczer

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists.
Kristin L Koenig, Ying Huang, Emily K Dotson, Shane Sheredy, Seema A Bhat, Tracy E Wiczer

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Addiction: Guidelines for Patients With Cancer.
Gretchen A McNally, Ashley Sica, Tracy Wiczer

Clin J Oncol Nurs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib.
Elizabeth M Kander, Qiuhong Zhao, Seema A Bhat, Jessica Hirsch, John C Byrd, Tracy Wiczer

Br J Haematol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension and incident cardiovascular events following ibrutinib initiation.
Tyler Dickerson, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Kyle Porter

Blood· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.
Kerry A Rogers, Luay Mousa, Qiuhong Zhao, Seema A Bhat, John C Byrd, Tracy E Wiczer

Leukemia· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
Megan K Phelps, Tracy E Wiczer, H Paige Erdeljac, Kelsey R Van Deusen, Kyle Porter

J Oncol Pharm Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia.
Ryan K DasGupta, Lauren Levine, Tracy Wiczer, Spero Cataland

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
Avirup Guha, Mohamed H Derbala, Qiuhong Zhao, Tracy E Wiczer, Jennifer A Woyach

J Am Coll Cardiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib.
Tracy E Wiczer, Lauren B Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao

Blood Adv· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
Tracy Wiczer, Emily Dotson, Amy Tuten, Gary Phillips, Kami Maddocks

J Oncol Pharm Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis